Cargando…

The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: A randomized controlled trial

OBJECTIVE: We report on the effect of hemoadsorption therapy to reduce cytokines in septic patients with respiratory failure. METHODS: This was a randomized, controlled, open-label, multicenter trial. Mechanically ventilated patients with severe sepsis or septic shock and acute lung injury or acute...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schädler, Dirk, Pausch, Christine, Heise, Daniel, Meier-Hellmann, Andreas, Brederlau, Jörg, Weiler, Norbert, Marx, Gernot, Putensen, Christian, Spies, Claudia, Jörres, Achim, Quintel, Michael, Engel, Christoph, Kellum, John A., Kuhlmann, Martin K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662220/ https://www.ncbi.nlm.nih.gov/pubmed/29084247 http://dx.doi.org/10.1371/journal.pone.0187015

Ejemplares similares

A multicenter randomized controlled study of an extracorporeal cytokine hemoadsorption device in septic patients
por: Schädler, D, et al.
Publicado: (2013)

Hemoadsorption eliminates remdesivir from the circulation: Implications for the treatment of COVID‐19
por: Biever, Paul, et al.
Publicado: (2021)

Alteco endotoxin hemoadsorption in Gram-negative septic shock patients
por: Shum, HP, et al.
Publicado: (2013)

Alteco endotoxin hemoadsorption in Gram-negative septic shock patients
por: Shum, Hoi Ping, et al.
Publicado: (2014)

Hemoadsorption by CytoSorb in septic patients: a case series
por: Kogelmann, Klaus, et al.
Publicado: (2017)

Experience with hemoadsorption (CytoSorb(®)) in the management of septic shock patients
por: Mehta, Yatin, et al.
Publicado: (2020)

Hemoadsorption corrects hyperresistinemia and restores anti-bacterial neutrophil function
por: Bonavia, Anthony, et al.
Publicado: (2017)

Use of extracorporeal endotoxin elimination therapy for septic shock
por: Adamik, BA, et al.
Publicado: (2013)

Longitudinal Cytokine Profiling in Patients with Severe COVID-19 on Extracorporeal Membrane Oxygenation and Hemoadsorption
por: Lebreton, Guillaume, et al.
Publicado: (2021)

Effect of extracorporeal hemoadsorption in critically ill patients with COVID-19: A narrative review
por: Chang, Kaixi, et al.
Publicado: (2023)

Hemoadsorption with CytoSorb(®) and the early course of linezolid plasma concentration during septic shock
por: Köhler, Thomas, et al.
Publicado: (2021)

Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19)
por: Asgharpour, Masoumeh, et al.
Publicado: (2020)

Sublingual Microcirculatory Evaluation of Extracorporeal Hemoadsorption with CytoSorb® in Abdominal Sepsis: A Case Report
por: Duran, Servet, et al.
Publicado: (2022)

Case Series: Efficacy and Safety of Hemoadsorption With HA-330 Adsorber in Septic Pediatric Patients With Cancer
por: Sazonov, Vitaliy, et al.
Publicado: (2021)

Immunomodulation by Hemoadsorption—Changes in Hepatic Biotransformation Capacity in Sepsis and Septic Shock: A Prospective Study
por: Praxenthaler, Janina, et al.
Publicado: (2022)

Clinical evaluation of endotoxin hemoadsorption therapy (PMX-DHP) for hypercytokinemia caused by septic multiple organ failure
por: Ikeda, T, et al.
Publicado: (2004)

Successful Extracorporeal Cytokine Hemoadsorption in a Marfan Syndrome Patient with COVID-19 Undergoing Redo Bentall Procedure
por: Singh, Ajmer, et al.
Publicado: (2023)

Hemoadsorption in LVAD Surgery: Suitable in Theory?
por: Ozturk, Mahmut, et al.
Publicado: (2023)

Bioassay for Endothelial Damage Mediators Retrieved by Hemoadsorption
por: Denzinger, Maximilian, et al.
Publicado: (2019)

The Effects of Hemoadsorption on the Kinetics of Antibacterial and Antifungal Agents
por: Berlot, Giorgio, et al.
Publicado: (2022)

Influence of Venoarterial Extracorporeal Membrane Oxygenation Integrated Hemoadsorption on the Early Reversal of Multiorgan and Microcirculatory Dysfunction and Outcome of Refractory Cardiogenic Shock
por: Soltesz, Adam, et al.
Publicado: (2022)

Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry
por: Hayanga, J. W. Awori, et al.
Publicado: (2023)

Hemoadsorption in the critically ill—Final results of the International CytoSorb Registry
por: Hawchar, Fatime, et al.
Publicado: (2022)

Hemoadsorption in a Case of Severe Septic Shock and Necrotizing Fasciitis Caused by Nontraumatic Renal Rupture due to Pyelonephritis with Obstructive Uropathy
por: Kousoulas, Lampros, et al.
Publicado: (2018)

Cardiogenic Shock in a Hemodialyzed Patient on Flecainide: Treatment with Intravenous Fat Emulsion, Extracorporeal Cardiac Life Support, and CytoSorb® Hemoadsorption
por: De Schryver, Nicolas, et al.
Publicado: (2019)

Extracorporeal hemoadsorption therapy as a potential therapeutic option for rapid removal of Apixaban in high risk-surgical patients: a case report
por: Dalmastri, Vittorio, et al.
Publicado: (2023)

Comment on: Extracorporeal hemoadsorption in critically ill COVID‑19 patients on VV ECMO: the CytoSorb therapy in COVID‑19 (CTC) registry
por: Supady, A., et al.
Publicado: (2023)

Effect of Hemoadsorption for Cytokine Removal in Pneumococcal and Meningococcal Sepsis
por: Leonardis, Francesca, et al.
Publicado: (2018)

Hemoadsorption efficacy for uncomplicated high-risk cardiac surgery
por: Redant, Sébastien, et al.
Publicado: (2019)

Intraoperative hemoadsorption in high-risk patients with infective endocarditis
por: Haidari, Zaki, et al.
Publicado: (2022)

Hemoadsorption with CytoSorb in Septic Shock Reduces Catecholamine Requirements and In-Hospital Mortality: A Single-Center Retrospective ‘Genetic’ Matched Analysis
por: Rugg, Christopher, et al.
Publicado: (2020)

First Evaluation of a New Dynamic Scoring System Intended to Support Prescription of Adjuvant CytoSorb Hemoadsorption Therapy in Patients with Septic Shock
por: Kogelmann, Klaus, et al.
Publicado: (2021)

The choice of catecholamines in septic shock: more and more good arguments to strengthen the known position, but don't lose the faith!
por: Meier-Hellmann, Andreas
Publicado: (2006)

Hemoadsorption therapy in the critically ill: solid base but clinical haze
por: Honoré, Patrick M., et al.
Publicado: (2019)

Hemoadsorption in Critical Care – It is a Useful or a Harmful Technique?
por: Kovacs, Judit
Publicado: (2020)

Pharmacokinetics of anti-infective agents during CytoSorb hemoadsorption
por: Schneider, Antoine G., et al.
Publicado: (2021)

Hemoadsorption in Complex Cardiac Surgery—A Single Center Experience
por: Manohar, Murali, et al.
Publicado: (2022)

Proteins Adsorbed during Intraoperative Hemoadsorption and Their In Vitro Effects on Endothelium
por: Piskovatska, Veronika, et al.
Publicado: (2023)

Use of a novel hemoadsorption device for cytokine removal as adjuvant therapy in a patient with septic shock with multi-organ dysfunction: A case study
por: Basu, Reshma, et al.
Publicado: (2014)

Influence of hemoadsorption during cardiopulmonary bypass on blood vesicle count and function
por: Wisgrill, Lukas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jeoovhnsoqkbnrbqhbk8hd7ung